4 April 2022
According to the Cancer Institute NSW, more than 4,000 people are diagnosed with lung cancer in NSW every year and it is the leading cause of all cancer deaths in NSW.
Each year, 676 people in Central and Eastern Sydney PHN will be told they have lung cancer and 468 will die from of the disease. Almost two-thirds of lung cancers spread before detection meaning early detection is key.
The Cancer Institute NSW is encouraging GPs to talk to their patients about the symptoms of lung cancer. They provide information to support GPs investigate symptoms of lung cancer and include links to online education, guidelines, and referral information for GPs to follow the optimal care pathway for people with lung cancer.
Read more on the Cancer Institute NSW’s website.
Health Referral Forms
Talking to your patients about lung cancer symptoms
About Central and Eastern Sydney PHN
About Membership
Advertise Employment
Allied Health
Check In On Your Wellbeing
Community Member
Contact
Cosprogram
Events
External Events Form
General Practice
General Practice Jobs
GP Psychiatry Support Line
headspace
Home
NewAccess Coaching
News
Privacy
Referral Services
Regional Mental Health and Suicide Prevention Plan
Resources and Links
Sitemap
SWCC Counselling Program
What We Do
Who We Are
Maroubra Medicare Urgent Care Clinic (UCC) is now open The Maroubra Medicare Urgent Care Clinic (UCC) is now open, seven days a week, from 8.00am to 8.00pm. It was officially launched by member for Kingsford Smith, the hon Matt Thistlethwaite MP (pictured at the launch with CESPHN CEO Nathalie Hansen…
Media Release: Central and Eastern Sydney PHN releases Healthy Ageing Strategy to empower older people In response to the increasing longevity and rapid growth of the older population the Central and Eastern Sydney Primary Health Network (CESPHN) is proud to release its new Healthy Ageing Strategy 2023-2028. This comprehensive strategy…
Immunisation Weekly Update: COVID-19 XBB.1.5 vaccine onboarding The Australian Government has accepted the latest advice from ATAGI on the use of the new COVID-19 XBB 1.5 vaccine as part of the National COVID-19 Vaccine Program. All sites currently participating in the COVID-19 Vaccination Program will be onboarded for the three…
Immunisation Weekly Update: Increase in COVID-19 infection cases ATAGI notes a recent increase in COVID-19 cases since November 2023 across Australia and encourages all eligible people who have not yet had their recommended 2023 COVID-19 vaccine dose/s to receive them as soon as possible. A first 2023 dose is recommended…
Immunisation Weekly Update: Vaccination coverage in RACF Australian Immunisation Register (AIR) data suggests that only 36% of people aged 70+ living in the central and eastern Sydney PHN region are immunised against Pneumococcal diseases. Immunisation providers are reminded to check AIR immunisation history statements of patients going into Residential Aged…
Immunisation Weekly Update: Introduction of Shingrix® to the NIP From 1 November 2023, the shingles vaccine Shingrix® will replace Zostavax® on the National Immunisation Program (NIP) schedule for the prevention of shingles and post-herpetic neuralgia. It will be available for eligible people most at risk of complications from shingles. A…
Continuing Professional Development (CPD) annual requirements Below is a snapshot of the continuing professional development (CPD) requirements for doctors, these include annual requirements of: completion of a Professional Development Plan 50 hours CPD each year, split across a range of activities: 25 hours – reviewing performance and measuring outcomes (with five hours minimum…
CESPHN’s Annual Report 2022-23 is now live Central and Eastern Sydney PHN has released its Annual Report 2022-23. The Annual Report is a summary of the key achievements and highlights for the PHN over the financial year. It is split into Improving Care Integration, Improving Practice and Commissioning Services to…
